Sabeni, Silvia
(2026)
Developing an in vivo model for RRM2B mitochondrial encephalomyopathy, [Dissertation thesis], Alma Mater Studiorum Università di Bologna.
Dottorato di ricerca in
Scienze mediche generali e scienze dei servizi, 38 Ciclo.
Documenti full-text disponibili:
Abstract
One of the major regulators of mitochondrial deoxyribonucleotide triphosphates (dNTPs) homeostasis is RNR, a cytosolic ribonucleotide reductase, belonging to the de novo pathway of dNTPs synthesis. It is responsible for the reduction of nucleotide diphosphates (NDPs) into deoxyribonucleotide diphosphates (dNDPs). It is a tetramer composed of two large subunits, R1, and two small subunits, R2 or p53-R2, in mitotic and post-mitotic cells, respectively. The small p53-R2 subunits, encoded by the gene RRM2B, contain the radical-generating centre, essential for the enzymatic reaction of RNR. Pathogenic variants in RRM2B cause severe mitochondrial DNA (mtDNA) depletion, leading to a broad spectrum of disorders. The most severe manifestation is a rare mitochondrial encephalomyopathy with early-onset lethality, occurring on average within the first four months of life. Additional phenotypes include progressive external ophthalmoplegia and a neurogastrointestinal MNGIE-like syndrome. To date, no effective therapy is available for this devastating condition. The aim of this PhD project was to generate an in vivo murine model recapitulating the severe clinical phenotype associated with RRM2B deficiency. Genetic manipulation of Rrm2b gene with the CRISPR/Cas9 technology was performed in mouse embryonic stem cells (mESCs). Selected clones lacking p53-R2 subunits were injected into blastocysts of pseudopregnant mice to generate chimeric mice. Breeding of those chimeras with wild-type mice produced heterozygous offspring, thereby establishing a novel Rrm2b-deficient mouse line. Molecular characterization confirmed the genetic disruption, with loss of Rrm2b transcript detected in brain and kidney tissues of heterozygous mice. Ongoing breeding strategies are aimed at generating homozygous knockout animals, expected to closely resemble the human mitochondrial encephalomyopathy phenotype. Once established, the Rrm2b-ko mouse model will enable comprehensive biochemical, behavioural, and motor characterization of RRM2B-related disease. This mouse model will allow detailed investigation of disease mechanisms and the evaluation of therapeutic strategies to treat one of the most devastating mitochondrial DNA depletion syndromes.
Abstract
One of the major regulators of mitochondrial deoxyribonucleotide triphosphates (dNTPs) homeostasis is RNR, a cytosolic ribonucleotide reductase, belonging to the de novo pathway of dNTPs synthesis. It is responsible for the reduction of nucleotide diphosphates (NDPs) into deoxyribonucleotide diphosphates (dNDPs). It is a tetramer composed of two large subunits, R1, and two small subunits, R2 or p53-R2, in mitotic and post-mitotic cells, respectively. The small p53-R2 subunits, encoded by the gene RRM2B, contain the radical-generating centre, essential for the enzymatic reaction of RNR. Pathogenic variants in RRM2B cause severe mitochondrial DNA (mtDNA) depletion, leading to a broad spectrum of disorders. The most severe manifestation is a rare mitochondrial encephalomyopathy with early-onset lethality, occurring on average within the first four months of life. Additional phenotypes include progressive external ophthalmoplegia and a neurogastrointestinal MNGIE-like syndrome. To date, no effective therapy is available for this devastating condition. The aim of this PhD project was to generate an in vivo murine model recapitulating the severe clinical phenotype associated with RRM2B deficiency. Genetic manipulation of Rrm2b gene with the CRISPR/Cas9 technology was performed in mouse embryonic stem cells (mESCs). Selected clones lacking p53-R2 subunits were injected into blastocysts of pseudopregnant mice to generate chimeric mice. Breeding of those chimeras with wild-type mice produced heterozygous offspring, thereby establishing a novel Rrm2b-deficient mouse line. Molecular characterization confirmed the genetic disruption, with loss of Rrm2b transcript detected in brain and kidney tissues of heterozygous mice. Ongoing breeding strategies are aimed at generating homozygous knockout animals, expected to closely resemble the human mitochondrial encephalomyopathy phenotype. Once established, the Rrm2b-ko mouse model will enable comprehensive biochemical, behavioural, and motor characterization of RRM2B-related disease. This mouse model will allow detailed investigation of disease mechanisms and the evaluation of therapeutic strategies to treat one of the most devastating mitochondrial DNA depletion syndromes.
Tipologia del documento
Tesi di dottorato
Autore
Sabeni, Silvia
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
38
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Mitochondrial DNA depletion, Ribonucleotide reductase, CRISPR/Cas9, mouse model.
Data di discussione
3 Luglio 2026
URI
Altri metadati
Tipologia del documento
Tesi di dottorato
Autore
Sabeni, Silvia
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
38
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Mitochondrial DNA depletion, Ribonucleotide reductase, CRISPR/Cas9, mouse model.
Data di discussione
3 Luglio 2026
URI
Gestione del documento: